Onyx Healthcare Statistics
Total Valuation
Onyx Healthcare has a market cap or net worth of TWD 6.10 billion. The enterprise value is 6.09 billion.
Market Cap | 6.10B |
Enterprise Value | 6.09B |
Important Dates
The last earnings date was Thursday, November 7, 2024.
Earnings Date | Nov 7, 2024 |
Ex-Dividend Date | Aug 1, 2024 |
Share Statistics
Onyx Healthcare has 38.61 million shares outstanding. The number of shares has increased by 0.90% in one year.
Current Share Class | n/a |
Shares Outstanding | 38.61M |
Shares Change (YoY) | +0.90% |
Shares Change (QoQ) | +0.17% |
Owned by Insiders (%) | 11.43% |
Owned by Institutions (%) | 0.03% |
Float | 12.13M |
Valuation Ratios
The trailing PE ratio is 33.67.
PE Ratio | 33.67 |
Forward PE | n/a |
PS Ratio | 4.71 |
PB Ratio | 4.13 |
P/TBV Ratio | 4.14 |
P/FCF Ratio | 56.75 |
P/OCF Ratio | n/a |
PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 29.37, with an EV/FCF ratio of 56.67.
EV / Earnings | 33.39 |
EV / Sales | 4.71 |
EV / EBITDA | 29.37 |
EV / EBIT | 32.88 |
EV / FCF | 56.67 |
Financial Position
The company has a current ratio of 2.09, with a Debt / Equity ratio of 0.18.
Current Ratio | 2.09 |
Quick Ratio | 1.13 |
Debt / Equity | 0.18 |
Debt / EBITDA | 1.86 |
Debt / FCF | 2.48 |
Interest Coverage | 30.54 |
Financial Efficiency
Return on equity (ROE) is 12.31% and return on invested capital (ROIC) is 4.42%.
Return on Equity (ROE) | 12.31% |
Return on Assets (ROA) | 3.58% |
Return on Capital (ROIC) | 4.42% |
Revenue Per Employee | 10.78M |
Profits Per Employee | 1.52M |
Employee Count | 120 |
Asset Turnover | 0.61 |
Inventory Turnover | 2.35 |
Taxes
Income Tax | n/a |
Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -3.20% in the last 52 weeks. The beta is 0.26, so Onyx Healthcare's price volatility has been lower than the market average.
Beta (5Y) | 0.26 |
52-Week Price Change | -3.20% |
50-Day Moving Average | 162.03 |
200-Day Moving Average | 166.83 |
Relative Strength Index (RSI) | 52.42 |
Average Volume (20 Days) | 38,408 |
Short Selling Information
Short Interest | n/a |
Short Previous Month | n/a |
Short % of Shares Out | n/a |
Short % of Float | n/a |
Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Onyx Healthcare had revenue of TWD 1.29 billion and earned 182.44 million in profits. Earnings per share was 4.69.
Revenue | 1.29B |
Gross Profit | 486.72M |
Operating Income | 121.16M |
Pretax Income | 213.80M |
Net Income | 182.44M |
EBITDA | 138.84M |
EBIT | 121.16M |
Earnings Per Share (EPS) | 4.69 |
Balance Sheet
The company has 283.59 million in cash and 266.32 million in debt, giving a net cash position of 17.27 million or 0.45 per share.
Cash & Cash Equivalents | 283.59M |
Total Debt | 266.32M |
Net Cash | 17.27M |
Net Cash Per Share | 0.45 |
Equity (Book Value) | 1.49B |
Book Value Per Share | 38.25 |
Working Capital | 428.48M |
Cash Flow
In the last 12 months, operating cash flow was 114.31 million and capital expenditures -6.81 million, giving a free cash flow of 107.50 million.
Operating Cash Flow | 114.31M |
Capital Expenditures | -6.81M |
Free Cash Flow | 107.50M |
FCF Per Share | 2.78 |
Margins
Gross margin is 37.63%, with operating and profit margins of 9.37% and 14.10%.
Gross Margin | 37.63% |
Operating Margin | 9.37% |
Pretax Margin | 16.53% |
Profit Margin | 14.10% |
EBITDA Margin | 10.73% |
EBIT Margin | 9.37% |
FCF Margin | 8.31% |
Dividends & Yields
This stock pays an annual dividend of 4.35, which amounts to a dividend yield of 2.77%.
Dividend Per Share | 4.35 |
Dividend Yield | 2.77% |
Dividend Growth (YoY) | 15.01% |
Years of Dividend Growth | 1 |
Payout Ratio | 91.86% |
Buyback Yield | -0.90% |
Shareholder Yield | 1.86% |
Earnings Yield | 2.97% |
FCF Yield | 1.76% |
Stock Splits
The last stock split was on August 1, 2024. It was a forward split with a ratio of 1.1499016.
Last Split Date | Aug 1, 2024 |
Split Type | Forward |
Split Ratio | 1.1499016 |
Scores
Onyx Healthcare has an Altman Z-Score of 7.48.
Altman Z-Score | 7.48 |
Piotroski F-Score | n/a |